RT Journal Article
SR Electronic
T1 Serologic Surveillance and Phylogenetic Analysis of SARS-CoV-2 Infection in Hospital Health Care Workers
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.01.10.21249440
DO 10.1101/2021.01.10.21249440
A1 Sikkens, Jonne J.
A1 Buis, David T.P.
A1 Peters, Edgar J.G.
A1 Dekker, Mireille
A1 Schinkel, Michiel
A1 Reijnders, Tom. D.Y.
A1 Schuurman, Alex. R.
A1 Brabander, Justin de
A1 Lavell, Ayesha H.A.
A1 Maas, Jaap. J.
A1 Koopsen, Jelle
A1 Han, Alvin X.
A1 Russell, Colin A.
A1 Schinkel, Janke
A1 Jonges, Marcel
A1 Matamoros, Sebastien P.F.
A1 Jurriaans, Suzanne
A1 van Mansfeld, Rosa
A1 Wiersinga, W. Joost
A1 Smulders, Yvo M.
A1 de Jong, Menno D.
A1 Bomers, Marije K.
YR 2021
UL http://medrxiv.org/content/early/2021/01/12/2021.01.10.21249440.abstract
AB BACKGROUND It is unclear how, when and where health care workers (HCW) working in hospitals are infected with SARS-CoV-2.METHODS Prospective cohort study comprising 4-weekly measurement of SARS-CoV-2 specific antibodies and questionnaires from March to June 2020. We compared SARS-CoV-2 incidence between HCW working in Covid-19 patient care, HCW working in non-Covid-19 patient care and HCW not in patient care. Phylogenetic analyses of SARS-CoV-2 samples from patients and HCW were performed to identify potential transmission clusters.RESULTS We included 801 HCW: 439 in the Covid-19 patient care group, 164 in the non-Covid-19 patient care group and 198 in the no patient care group. SARS-CoV-2 incidence was highest in HCW working in Covid-19 patient care (13.2%), as compared with HCW in non-Covid-19 patient care (6.7%, hazard ratio [HR] 2.2, 95% confidence interval [CI] 1.2 to 4.3) and in HCW not working in patient care (3.6%, HR 3.9, 95% CI 1.8 to 8.6). Within the group of HCW caring for Covid-19 patients, SARS-CoV-2 cumulative incidence was highest in HCW working on Covid-19 wards (25.7%), as compared with HCW working on intensive care units (7.1%, HR 3.6, 95% CI 1.9 to 6.9), and HCW working in the emergency room (8.0%, HR 3.3, 95% CI 1.5 to 7.1). Phylogenetic analyses on Covid-19 wards identified multiple potential HCW-to-HCW transmission clusters while no patient-to-HCW transmission clusters were identified.CONCLUSIONS HCW working on Covid-19 wards are at increased risk for nosocomial SARS-CoV-2 infection, with an important role for HCW-to-HCW transmission.(Funded by the Netherlands Organization for Health Research and Development ZonMw & the Corona Research Fund Amsterdam UMC; Netherlands Trial Register number NL8645)Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNetherlands Trial Register number NL8645Funding StatementFunded by the Netherlands Organization for Health Research and Development ZonMw & the Corona Research Fund Amsterdam UMCAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Amsterdam UMC location VUmc institutional review boardAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are not made public at the moment. Please contact corresponding author for data requests.